AMERICAN COLLEGE OF RADIOLOGY
Return to Table of Contents 120
References
1. Do RKG, Dick DW. PET/MRI: safety considerations. In: Iagaru A, Hope T, Veit-Haibach P, eds. PET/MRI in Oncology.
Springer; 2018:115-130.
2. Johnston T, Moser R, Moeller K, Moriarty TM. Intraoperative MRI: safety. Neurosurg Clin N Am. 2009;20(2):147-153.
doi: 10.1016/j.nec.2009.04.007
3. Rai R, Kumar S, Batumalai V, et al. The integration of MRI in radiation therapy: collaboration of radiographers
and radiation therapists. J Med Radiat Sci. 2017;64(1):61-68. doi: 10.1002/jmrs.225
4. Parasuram NR, Crawford AL, Mazurek MH, et al. Future of neurology & technology: neuroimaging made
accessible using low-field, portable MRI. Neurology. 2023;100(22):1067-1071. doi:
10.1212/WNL.0000000000207074
5. Kacher DF, Fairhurst J, Vacanti JC, Tempany-Afdhal CM, Mukundan S Jr. Chapter 31: Safety issues for
interventional MR systems. In: Shellock FG, Crues JV III, eds. MRI Bioeffects, Safety, and Management.
Biomedical Research Publishing Group; 2014:833-868.
6. Kamvosoulis P, Currie GM. PET/MRI, part 1: establishing a PET/MRI facility. J Nucl Med Technol. 2021;49(2):120-125.
doi: 10.2967/jnmt.120.261339
7. Parikh N, Friedman KP, Shah SN, Chandarana H. Practical guide for implementing hybrid PET/MR clinical service:
lessons learned from our experience. Abdom Imaging. 2015;40(6):1366-1373. doi: 10.1007/s00261-015-0444-6
8. van Osch MJP, Webb AG. Safety of ultra-high field MRI: what are the risks? Curr Radiol Rep. 2014;2:61. doi:
10.1007/s40134-014-0061-0
9. United States Nuclear Regulatory Commission. Medical uses of nuclear materials. Published June 23, 2021.
Accessed April 22, 2024. https://www.nrc.gov/materials/miau/med-use.html
10. Mittauer K, Paliwal B, Hill P, et al. A new era of image guidance with magnetic resonance-guided radiation therapy
for abdominal and thoracic malignancies. Cureus. 2018;10(4):e2422. doi: 10.7759/cureus.2422
11. Glide-Hurst CK, Paulson ES, McGee K, et al. Task group 284 report: magnetic resonance imaging simulation in
radiotherapy: considerations for clinical implementation, optimization, and quality assurance. Med Phys.
2021;48(70):e636-e70. doi: 10.1002/mp.14695
12. US Food and Drug Administration. Criteria for significant risk investigations of magnetic resonance diagnostic
devices. Published June 20, 2014. Accessed April 22, 2024. https://www.fda.gov/media/71385/download
13. US Food and Drug Administration. FDA clears first 7T magnetic resonance imaging device. Published October 12,
2017. Accessed April 22, 2024.
https://www.fda.gov/news-events/press-announcements/fda-clears-first-7t-
magnetic-resonance-imaging-device
14. Hoff MN, McKinney At, Shellock FG, et al. Safety considerations of 7-T MRI in clinical practice. Radiology.
2019;292(3):509-518. doi: 10.1148/radiol.2019182742
15. International Commission on Non-Ionizing Radiation Protection. Guidelines on limits of exposure to static magnetic
fields. Health Phys. 2009;96(4):504-514. doi: 10.1097/01.HP.0000343164.27920.4a
16. Kraff O, Quick HH. Chapter 3: MRI physics and safety at 7 tesla. In: Shellock FG, Crues JV III, eds. MRI Bioeffects,
Safety, and Patient Management. 2nd ed. Biomedical Research Publishing Group; 2022:71-95.
17. Dula AN, Virostko J, Shellock FG. Assessment of MRI issues at 7 T for 28 implants and other objects. AJR Am J
Roentgenol. 2014;202(2):401-405. doi: 10.2214/AJR.13.10777
18. Shaffer A, Weisbaum D, Naik A, et al. Neurosurgical implant safety in 7 T MRI: a scoping review. J Magn Reson
Imaging. 2023;57(3):661-669. doi: 10.1002/jmri.28449
19. Fagan AJ, Bitz AK, Björkman-Burtscher IM, et al. 7T MR Safety. J Magn Reson Imaging. 2021;53(2):333-346. doi:
10.1002/jmri.27319
20. Mirzayan MJ, Klinge PM, Samii M, Goetz F, Krauss JK. MRI safety of a programmable shunt assistant at 3 and 7
Tesla. Br J Neurosurg. 2012;26(3):397-400. doi: 10.3109/02688697.2011.625060
21. Cho SM, Wilcox C, Keller S, et al. Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic
Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience.
Crit Care. 2022;26(1):119. doi: 10.1186/s13054-022-03990-6
22. Shellock FG, Rosen MS, Webb A, et al. Managing Patients With Unlabeled Passive Implants on MR Systems
Operating Below 1.5 T. J Magn Reson Imaging. Published online September 28, 2023. doi:10.1002/jmri.29002